MAP2K7 and neoplasm: Furthermore, activation of MEK promotes tumor cell growth, proliferation, and survival, and, as such, dual inhibition of BRAF and MEK has been proposed as a therapeutic strategy in BRAF V600E-altered tumors [22,27,74,75,76,77,78,79,80,81,82,83].